Company Overview and News

0
Expansion of ASEAN food corporations

2018-07-16 bworldonline
Many Philippine companies expand overseas to reach more consumers and increase revenues. Also, companies can utilize global markets to introduce unique products and services (https://www.bizjournals.com/).
SMCP1 UNITDSPR JBFCY PDMXY UVRBY RI SMGBY SMGBF 532432 SMC2B SMC2A JBFCF SMC SMC2D SMC2C SMC2F JFC DMPLF URC SMC2E UQNTY DMPL D03 UVRBF

1
Del Monte Pacific Ltd. ADR 2018 Q4 - Results - Earnings Call Slides

2018-06-29 seekingalpha
The following slide deck was published by Del Monte Pacific Ltd. ADR in conjunction with their 2018 Q4 earnings call.
DMPLF PDMXY DMPL D03

1
Del Monte suffers net loss thanks to plant closures

2018-06-29 bworldonline
DEL MONTE Pacific Limited (DMPL) swung to a net loss for the fiscal year ending April 2018, dragged by the closure of two plants in the United States.
DMPLF DMPL PDMXY D03

1
Del Monte Pacific reports net loss due to closure of two US plants

2018-06-29 bworldonline
Del Monte Pacific Limited (DMPL) swung to a net loss for the fiscal year ending April 2018, dragged by the closure of two plants in the United States.
DMPLF DMPL PDMXY D03

1
Del Monte Pacific 4Q earnings surge on one-off but FY18 still ends with US$28m loss

2018-06-29 theedgemarkets
SINGAPORE (June 29): Del Monte Pacific (DMPL), the producer of branded fruits and vegetable, juices and condiments, reported 4Q earnings ended April of US$12.3 million (S$16.8 million), four times higher than the US$2.9 million in the same quarter last year.
DMPLF DMPL PDMXY D03

6
Del Monte Philippines books P2.6-B profit

2018-06-20 bworldonline
DEL MONTE Philippines, Inc. (DMPI)’s net income was flat for its fiscal year ending April 2018, due to higher interest expenses amid a single-digit growth in sales.
PSKXF DMPLF DMPL PHSXY PDMXY PSE D03

6
Del Monte Philippines defers IPO

2018-06-08 bworldonline
DEL MONTE Philippines, Inc. (DMPI) has delayed what would have been the country’s first initial public offering this year, citing the current volatility in the local stock market.
PSKXF DMPLF DMPL PHSXY PDMXY PSE D03

6
Del Monte Philippines defers IPO

2018-06-07 business.inquirer.net
Food producer Del Monte Philippines Inc. has deferred its P17.55-billion initial public offering, citing turbulent market conditions.
PSKXF DMPLF DMPL PHSXY PDMXY PSE D03

1
Del Monte PHL’s IPO gets PSE go-ahead

2018-05-31 bworldonline
THE Philippine Stock Exchange has given the greenlight for the P17.5-billion initial public offering (IPO) of Del Monte Philippines, Inc. (DMPI) on Thursday.
DMPLF DMPL PDMXY D03

6
PSE approves Del Monte Philippines’ P17.5-billion IPO

2018-05-31 bworldonline
The Philippine Stock Exchange has given the greenlight for the P17.5-billion initial public offering (IPO) of Del Monte Philippines, Inc. (DMPI) on Thursday.
PSKXF DMPLF DMPL PHSXY PDMXY PSE D03

6
PSE oks Del Monte PH’s P17.55B IPO

2018-05-31 business.inquirer.net
The Philippine Stock Exchange has approved a P17.55-billion initial public offering by food producer Del Monte Philippines Inc. (DMPI), the local unit of Campos family-led multi-national conglomerate Del Monte Pacific Ltd., by June.
PSKXF DMPLF DMPL PHSXY PDMXY PSE D03

2
SEC approves Del Monte PHL IPO

2018-05-25 bworldonline
CANNED FRUIT manufacturer Del Monte Philippines, Inc. (DMPI) has secured approval from the Securities and Exchange Commission (SEC) for its proposed P17.5-billion initial public offering (IPO).
DMPLF DMPL PDMXY D03

7
How Trump’s steel tariffs kick the can business

2018-05-10 thestar.com.my
SAN FRANCISCO: Dan Vincent is in a bind. The president of Pacific Coast Producers (PCP) plans to use around 700 million tin-coated steel cans this year for tomatoes, peaches and pears from 168 growers here in California.
SYY KR DMPLF DMPL PDMXY D03

7
How Trump's steel tariffs kick the can business

2018-05-10 reuters
The president of Pacific Coast Producers (PCP) plans to use around 700 million tin-coated steel cans this year for tomatoes, peaches and pears from 168 growers here in California.
SYY KR DMPLF DMPL PDMXY D03

7
How Trump's steel tariffs kick the can business

2018-05-10 reuters
The president of Pacific Coast Producers (PCP) plans to use around 700 million tin-coated steel cans this year for tomatoes, peaches and pears from 168 growers here in California.
SYY KR DMPLF DMPL PDMXY D03

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...